Corbion (CRBN) Q1 2025 earnings summary

Executive summary

• Q1 2025 sales reached €329.7 million, with organic sales growth of 7.9% year-over-year, driven by strong volume/mix gains and efficiency improvements.

• Adjusted EBITDA rose to €54.4 million, with a margin of 16.5%, reflecting significant operational leverage and cost savings.

• Free cash flow for the quarter was €8.6 million, supporting the affirmation of the FY 2025 outlook.

• Operating profit increased 186% organically to €34.0 million, reflecting efficiency and cost management.

Financial highlights

• Sales increased 9.8% year-over-year to €329.7 million, with volume/mix up 8.4% and pricing down 0.5%.

• Adjusted EBITDA grew 57.7% to €54.4 million, with the margin improving from 11.5% to 16.5%.

• Free cash flow for Q1 was €8.6 million.

• Operating profit margin exceeded 10%, with significant year-over-year growth.

Outlook and guidance

• Full-year 2025 outlook affirmed, with guidance on volume/mix, Adjusted EBITDA, and free cash flow unchanged.

• Organic adjusted EBITDA growth above 25% expected for 2025.

• Anticipates organic volume/mix growth of 2%-6% for the year.

• Free cash flow (excluding acquisitions/divestments) projected to exceed €85 million; capex spend planned at €80–90 million.

• Year-end covenant net debt/EBITDA targeted at approximately 1.6x.